-
1
-
-
0030594838
-
Human gene marker/therapy clinical protocols
-
Anonymous. 1996. Human gene marker/therapy clinical protocols. Hum. Gene Ther. 7:1621-1647.
-
(1996)
Hum. Gene Ther.
, vol.7
, pp. 1621-1647
-
-
-
2
-
-
0029877210
-
Herpes simplex virus thymidine kinase gene-transfected tumor cells: Sensitivity to antiherpetic drugs
-
Balzarini, J. 1996. Herpes simplex virus thymidine kinase gene-transfected tumor cells: sensitivity to antiherpetic drugs. Nucleosides Nucleotides 15:821-831.
-
(1996)
Nucleosides Nucleotides
, vol.15
, pp. 821-831
-
-
Balzarini, J.1
-
3
-
-
0028238797
-
Comparative cytostatic activity of different antiherpetic drugs against herpes simplex virus thymidine kinase genetransfected tumor cells
-
Balzarini, J., C. Bohman, R.T. Walker and E. De Clercq. 1994. Comparative cytostatic activity of different antiherpetic drugs against herpes simplex virus thymidine kinase genetransfected tumor cells. Mol. Pharmacol. 45:1253-1258.
-
(1994)
Mol. Pharmacol.
, vol.45
, pp. 1253-1258
-
-
Balzarini, J.1
Bohman, C.2
Walker, R.T.3
De Clercq, E.4
-
4
-
-
0022377534
-
Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2′-deoxyuridine derivatives for murine mammary carcinoma (FM3A) cell transformed with the herpes simplex virus type 1 thymidine kinase gene
-
Balzarini, J., E. De Clercq, A. Verbruggen, D. Ayusawa and T. Seno. 1985. Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2′-deoxyuridine derivatives for murine mammary carcinoma (FM3A) cell transformed with the herpes simplex virus type 1 thymidine kinase gene. Mol. Pharmacol. 25:581-587.
-
(1985)
Mol. Pharmacol.
, vol.25
, pp. 581-587
-
-
Balzarini, J.1
De Clercq, E.2
Verbruggen, A.3
Ayusawa, D.4
Seno, T.5
-
5
-
-
0027480081
-
Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2′-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl) guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2
-
Balzarini, J., C. Bohman and E. De Clercq. 1993. Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2′-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl) guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2. J. Biol. Chem. 265:6332-6337.
-
(1993)
J. Biol. Chem.
, vol.265
, pp. 6332-6337
-
-
Balzarini, J.1
Bohman, C.2
De Clercq, E.3
-
6
-
-
0029084206
-
Novel (E)-5-(2-iodovinyl)-2′-deoxyuridine derivatives as potential cytostatic agents against herpes simplex virus thymidine kinase gene transfected tumors
-
Balzarini, J., K.W. Morin, E.E. Knaus, L.I. Wiebe and E. De Clercq. 1995. Novel (E)-5-(2-iodovinyl)-2′-deoxyuridine derivatives as potential cytostatic agents against herpes simplex virus thymidine kinase gene transfected tumors. Gene Ther. 2:317-322.
-
(1995)
Gene Ther.
, vol.2
, pp. 317-322
-
-
Balzarini, J.1
Morin, K.W.2
Knaus, E.E.3
Wiebe, L.I.4
De Clercq, E.5
-
7
-
-
0028310825
-
Mechanism of cytostatic action of novel 5-(thien-2-yl)- and 5-(furan-2-yl)-substituted pyrimidine nucleoside analogues against tumor cells transfected by the thymidine kinase gene of herpes simplex virus
-
Bohman, C., J. Balzarini, P. Wigerinck, A. Van Aerschot, P. Herdewijn and E. De Clercq. 1994. Mechanism of cytostatic action of novel 5-(thien-2-yl)- and 5-(furan-2-yl)-substituted pyrimidine nucleoside analogues against tumor cells transfected by the thymidine kinase gene of herpes simplex virus. J. Biol. Chem. 269:8036-8043.
-
(1994)
J. Biol. Chem.
, vol.269
, pp. 8036-8043
-
-
Bohman, C.1
Balzarini, J.2
Wigerinck, P.3
Van Aerschot, A.4
Herdewijn, P.5
De Clercq, E.6
-
8
-
-
0026599048
-
One-step transformation of yeast in stationary phase
-
Chen, D.C., B.C. Yang and T.T. Kuo. 1992. One-step transformation of yeast in stationary phase. Curr. Genet. 21:83-84.
-
(1992)
Curr. Genet.
, vol.21
, pp. 83-84
-
-
Chen, D.C.1
Yang, B.C.2
Kuo, T.T.3
-
9
-
-
0026772206
-
In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors
-
Culver, K.W., Z. Ram, S. Wallbridge, H. Ishii, E.H. Oldfield and R.M. Blaese. 1992. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256:1550-1552.
-
(1992)
Science
, vol.256
, pp. 1550-1552
-
-
Culver, K.W.1
Ram, Z.2
Wallbridge, S.3
Ishii, H.4
Oldfield, E.H.5
Blaese, R.M.6
-
10
-
-
0029553879
-
Trends in the development of new antiviral agents for the chemotherapy of infections caused by herpesviruses and retroviruses
-
De Clercq, E. 1995. Trends in the development of new antiviral agents for the chemotherapy of infections caused by herpesviruses and retroviruses. Rev. Med. Virol. 5:149-164.
-
(1995)
Rev. Med. Virol.
, vol.5
, pp. 149-164
-
-
De Clercq, E.1
-
11
-
-
0345814045
-
Varicella-zoster virus thymidine kinase gene and antiherpetic pyrimidine nucleoside analogues in a combined gene/chemotherapy treatment for cancer
-
Degreve, B., G. Andrei, M. Izquierdo, J. Piette, K. Morin, E.E. Knaus, L.I. Wiebe, I. Basrah et al. 1997. Varicella-zoster virus thymidine kinase gene and antiherpetic pyrimidine nucleoside analogues in a combined gene/chemotherapy treatment for cancer. Gene Ther. 4:1107-1114.
-
(1997)
Gene Ther.
, vol.4
, pp. 1107-1114
-
-
Degreve, B.1
Andrei, G.2
Izquierdo, M.3
Piette, J.4
Morin, K.5
Knaus, E.E.6
Wiebe, L.I.7
Basrah, I.8
-
12
-
-
0027548077
-
Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir
-
Oldfield, E.H., Z. Ram, K.W. Culver, R.M. Blaese, H.L. DeVroom and W.F. Anderson. 1993. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum. Gene Ther. 4:39-69.
-
(1993)
Hum. Gene Ther.
, vol.4
, pp. 39-69
-
-
Oldfield, E.H.1
Ram, Z.2
Culver, K.W.3
Blaese, R.M.4
DeVroom, H.L.5
Anderson, W.F.6
-
13
-
-
0031463632
-
Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells
-
Ram, Z., K.W. Culver, E.M. Oshiro, J.J. Viola, H.L. DeVroom, E. Otto, Z. Long, Y. Chiang et al. 1997. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat. Med. 3:1354-1361.
-
(1997)
Nat. Med.
, vol.3
, pp. 1354-1361
-
-
Ram, Z.1
Culver, K.W.2
Oshiro, E.M.3
Viola, J.J.4
DeVroom, H.L.5
Otto, E.6
Long, Z.7
Chiang, Y.8
-
14
-
-
0021352397
-
Inhibition of cellular (DNA polymerase and herpes simplex virus-induced DNA polymerases by the triphosphate of BW759U
-
St. Clair, M.H., W.H. Miller, R.L. Miller, C.U. Lambe and P.A. Furman. 1984. Inhibition of cellular (DNA polymerase and herpes simplex virus-induced DNA polymerases by the triphosphate of BW759U. Antimicrob. Agents Chemother. 25:191-194.
-
(1984)
Antimicrob. Agents Chemother
, vol.25
, pp. 191-194
-
-
St Clair, M.H.1
Miller, W.H.2
Miller, R.L.3
Lambe, C.U.4
Furman, P.A.5
|